98%
921
2 minutes
20
Background: In 2019 the English National Health Service (NHS) launched a national de-adoption programme to stop or limit access to surgical procedures considered to have little, or uncertain, evidence of benefit to justify their risks and/or costs: the Evidence-Based Interventions (EBI) programme. Central to the programme was the publication of guidance detailing clinical recommendations targeting 17 surgical procedures: four to be stopped and 13 to be restricted to patients satisfying specific criteria. Local commissioning organisations, NHS bodies responsible for purchasing surgical services, were instructed to reflect national EBI recommendations in their local commissioning policies. This study (which is part of the NIHR OLIVIA study, an evaluation of the EBI programme) assessed local commissioning policy compliance with EBI recommendations and identified funding mechanisms employed locally to promote enforcement.
Methods: A documentary analysis was conducted on a purposive sample of local commissioning policies for each of the 17 EBI surgical procedures. Local policies were compared to EBI recommendations and any differences were categorised against an established five category framework for capturing differences in local policies. Funding mechanisms were also recorded. Data were analysed using descriptive statistics supported by written summaries to describe the nature of discrepancies between local and national recommendations.
Results: Three hundred six local commissioning policies were analysed. 72% (44/61) of procedures to be stopped and 43% (106/245) of restricted access policies matched EBI recommendations. Concordance rates varied by surgical procedures. Where local policies for the 13 restricted access procedures differed, variations were most commonly categorised as differences in diagnostic approach followed by differences in specification of symptom severity and disease progression. The funding mechanism most frequently stated for the stopped procedures was ‘Individual Funding Request’ (74%, 45/61), whilst for restricted access procedures, policies relied on ‘Criteria Based Access’ (48%, 117/245) followed by ‘Prior Approval’ (33%, 80/245).
Conclusion: This study, to our knowledge, is the first to explore variation between local and national de-adoption policies. With under half of local commissioning policies matching national EBI recommendations, reliance on the take up of national de-adoption policy is inadequate. More support is needed for local commissioners to reflect national guidance.
Supplementary Information: The online version contains supplementary material available at 10.1186/s12913-025-13012-0.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12309202 | PMC |
http://dx.doi.org/10.1186/s12913-025-13012-0 | DOI Listing |
Adv Healthc Mater
September 2025
State Key Laboratory of Southwestern Chinese Medicine Resources, College of Modern Chinese Medicine Industry, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation, damage, and disability. Activated fibroblast-like synoviocytes (FLSs), abundant in RA synovium, crucially facilitate disease progression. These activated FLSs drive RA pathogenesis by upregulating adhesion molecules, proinflammatory cytokines, chemokines, and major histocompatibility complex class II (MHC-II).
View Article and Find Full Text PDFSurgery
September 2025
Department of Surgery, University of Chicago, Chicago, IL. Electronic address: https://twitter.com/selwyn_rogers.
Public policy and health care are demonstrably interconnected. Medical and surgical outcomes are inseparableable from the political processes and laws that govern our nation. Health care delivery and public health are shaped by public discourse in city councils, county commissions, and state/national legislatures and agencies.
View Article and Find Full Text PDFJ Magn Reson Imaging
September 2025
Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
Background: Parkinson's disease (PD) often presents with lateralized motor symptoms at onset, reflecting asymmetric degeneration of the substantia nigra (SN). Neuromelanin (NM) loss and iron accumulation are hallmarks of SN pathology in PD, but their spatial distribution and interrelationship in PD patients with right-sided (PDR) or left-sided (PDL) motor symptom onset remain unclear.
Purpose: To investigate the spatial vulnerability and interrelationship of NM and iron in the SN among PDR, PDL, and healthy controls (HCs) using MRI.
Waste Manag
September 2025
Shanghai Engineering Research Center of Solid Waste Treatment and Resource Recovery, School of Environmental Science & Engineering, Shanghai Jiao Tong University, Shanghai 200240, China; China Institute for Urban Governance, Shanghai Jiao Tong University, Shanghai 200240, China. Electronic address:
As one of the major sources of greenhouse gas (GHG) emissions, the municipal solid waste (MSW) management system was regarded as a key contributor to the construction of a low-carbon society. Understanding the evolution of waste treatment facilities and the corresponding GHG emissions was essential for assessing the low-carbon competitiveness of local communities. In this study, facility-level data were used to estimate GHG emissions from the waste management system in the Yangtze River Delta (YRD) and analyze their temporal and spatial variations.
View Article and Find Full Text PDFWorld J Urol
September 2025
Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France.
Purpose: In 5-10% of cases, renal cancer extends into the venous system, particularly the inferior vena cava (IVC), which worsens prognosis. This study aims to assess morbidity, mortality, and oncological outcomes of patients treated surgically for renal cancer with IVC extension over a 30-year period, in two experienced centers.
Materials And Methods: This bicentric, retrospective study analyzed patients treated between 1988 and 2020 for renal cancer involving the IVC.